JP2023052043A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023052043A5 JP2023052043A5 JP2022205718A JP2022205718A JP2023052043A5 JP 2023052043 A5 JP2023052043 A5 JP 2023052043A5 JP 2022205718 A JP2022205718 A JP 2022205718A JP 2022205718 A JP2022205718 A JP 2022205718A JP 2023052043 A5 JP2023052043 A5 JP 2023052043A5
- Authority
- JP
- Japan
- Prior art keywords
- ecm
- low
- pharmaceutical composition
- composition
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002540 macrophage Anatomy 0.000 claims 8
- 210000001054 cardiac fibroblast Anatomy 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 3
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 3
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 3
- 210000002744 extracellular matrix Anatomy 0.000 claims 3
- 102000008096 B7-H1 Antigen Human genes 0.000 claims 2
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 2
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 2
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 2
- 102100025136 Macrosialin Human genes 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 210000001808 exosome Anatomy 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2018628 | 2017-03-31 | ||
| NL2018628 | 2017-03-31 | ||
| JP2019553818A JP7249951B2 (ja) | 2017-03-31 | 2018-03-30 | 標的臓器の細胞外構成成分を使用する治療用細胞の作製 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553818A Division JP7249951B2 (ja) | 2017-03-31 | 2018-03-30 | 標的臓器の細胞外構成成分を使用する治療用細胞の作製 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023052043A JP2023052043A (ja) | 2023-04-11 |
| JP2023052043A5 true JP2023052043A5 (https=) | 2023-08-18 |
| JP7419490B2 JP7419490B2 (ja) | 2024-01-22 |
Family
ID=58548819
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553818A Active JP7249951B2 (ja) | 2017-03-31 | 2018-03-30 | 標的臓器の細胞外構成成分を使用する治療用細胞の作製 |
| JP2022205718A Active JP7419490B2 (ja) | 2017-03-31 | 2022-12-22 | 標的臓器の細胞外構成成分を使用する治療用細胞の作製 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553818A Active JP7249951B2 (ja) | 2017-03-31 | 2018-03-30 | 標的臓器の細胞外構成成分を使用する治療用細胞の作製 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11760975B2 (https=) |
| EP (1) | EP3600354B1 (https=) |
| JP (2) | JP7249951B2 (https=) |
| AU (1) | AU2018243554C1 (https=) |
| CA (1) | CA3058437A1 (https=) |
| DK (1) | DK3600354T3 (https=) |
| WO (1) | WO2018183825A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3145493T3 (da) | 2014-05-18 | 2022-10-31 | Childrens Medical Center | Fremgangsmåder og sammensætninger vedrørende exosomer |
| US11738046B2 (en) | 2017-11-03 | 2023-08-29 | Wisconsin Alumni Research Foundation | Macrophage cell therapy to treat orthopedic injury |
| US11499730B2 (en) | 2018-02-12 | 2022-11-15 | Wisconsin Alumni Research Foundation | LPS priming of stromal cells to generate LPS-specific exosome educated macrophages |
| JP7538044B2 (ja) | 2018-04-30 | 2024-08-21 | ザ チルドレンズ メディカル センター コーポレーション | 間葉系間質細胞エキソソームおよびそれらの使用 |
| CA3099042A1 (en) * | 2018-05-09 | 2019-11-14 | Children's Medical Center Corporation | Mesenchymal stromal cell exosome -treated monocytes and uses thereof |
| JP7513284B2 (ja) * | 2019-03-08 | 2024-07-09 | 国立大学法人 新潟大学 | マクロファージの誘導方法、抗炎症性マクロファージの誘導剤及び医薬組成物 |
| EP4135727A4 (en) * | 2020-04-16 | 2024-05-22 | University of Pittsburgh - of the Commonwealth System of Higher Education | MATRIX-BOUND VESICLES (MBV) FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME |
| EP3984527A1 (en) | 2020-10-13 | 2022-04-20 | Ludwig-Maximilians-Universität München | Nano-in-micro encapsulated sirna dry powder, method for producing the same and use of a powder formulation as a pharmaceutical dosage form, in particular for pulmonary delivery |
| US20220127579A1 (en) * | 2020-10-22 | 2022-04-28 | Wisconsin Alumni Research Foundation | Use of Toll-Like Receptor 4 Agonists to Treat Inflammation and Tissue Injury |
| WO2023003775A2 (en) * | 2021-07-21 | 2023-01-26 | The Regents Of The University Of California | Human ipsc-derived macrophages for liver repair and regeneration |
| CA3230583A1 (en) * | 2021-09-07 | 2023-03-16 | Eric Schmuck | Cardiac fibroblast derived extracellular matrix |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120081972A (ko) * | 2009-07-02 | 2012-07-20 | 아이티에이치 임뮨 세라피 홀딩스 에이비 | 엑소좀에 기초한 암의 치료 |
| US8647678B2 (en) * | 2009-08-24 | 2014-02-11 | Wisconsin Alumni Research Foundation | Anti-inflammatory macrophages and uses thereof |
| WO2013028968A1 (en) | 2011-08-25 | 2013-02-28 | Wisconsin Alumni Research Foundation | 3-dimensional cardiac fibroblast derived extracellular matrix |
| WO2015031376A1 (en) * | 2013-08-26 | 2015-03-05 | The Trustees Of Columbia University In The City Of New York | Scaffolds containing cytokines for tissue engineering |
| US10624930B2 (en) | 2014-06-10 | 2020-04-21 | Mesoblast International Sarl | Treatment of immune disorders |
| US10166254B2 (en) | 2014-09-19 | 2019-01-01 | Wisconsin Alumni Research Foundation | Use of mesenchymal stem cell-educated macrophages to treat and prevent graft versus host disease and radiation-induced injury |
| US20170304368A1 (en) * | 2014-10-06 | 2017-10-26 | Cedars-Sinai Medical Center | Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells |
| JP7468983B2 (ja) | 2015-06-03 | 2024-04-16 | ウィスコンシン アラムニ リサーチ ファンデーション | 虚血性疾患または虚血性損傷を処置するための心臓線維芽細胞由来細胞外マトリックスおよびその注射可能製剤 |
| US11738046B2 (en) | 2017-11-03 | 2023-08-29 | Wisconsin Alumni Research Foundation | Macrophage cell therapy to treat orthopedic injury |
-
2018
- 2018-03-30 US US15/941,409 patent/US11760975B2/en active Active
- 2018-03-30 CA CA3058437A patent/CA3058437A1/en active Pending
- 2018-03-30 AU AU2018243554A patent/AU2018243554C1/en active Active
- 2018-03-30 DK DK18720454.0T patent/DK3600354T3/da active
- 2018-03-30 JP JP2019553818A patent/JP7249951B2/ja active Active
- 2018-03-30 EP EP18720454.0A patent/EP3600354B1/en active Active
- 2018-03-30 WO PCT/US2018/025371 patent/WO2018183825A1/en not_active Ceased
-
2022
- 2022-12-22 JP JP2022205718A patent/JP7419490B2/ja active Active
-
2023
- 2023-08-17 US US18/451,617 patent/US20230407256A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023052043A5 (https=) | ||
| JP2020511999A5 (https=) | ||
| Dabrowska et al. | Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases | |
| Tan et al. | CD73 expression on mesenchymal stem cells dictates the reparative properties via its anti‐inflammatory activity | |
| Gandia et al. | Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction | |
| Stuart et al. | Tumor-promoting phorbol esters stimulate hematopoietic colony formation in vitro | |
| Wan et al. | Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing | |
| JP2021532091A5 (https=) | ||
| KR100310499B1 (ko) | 메티오날 또는 말론디알데히드의 세포 내 비율에 영향을 치는 인자를 함유하는 세포소멸 조절 조성물 | |
| JP2022507616A5 (https=) | ||
| JP2021532094A5 (https=) | ||
| WO2007097993A2 (en) | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor | |
| JP2021532093A5 (https=) | ||
| Vacca et al. | MSC and innate immune cell interactions: a lesson from human decidua | |
| Lee et al. | Ascorbic acid 2-Glucoside stably promotes the primitiveness of embryonic and mesenchymal stem cells through Ten–Eleven Translocation-and cAMP-Responsive Element-Binding Protein-1-Dependent mechanisms | |
| Wang et al. | Apoptotic mesenchymal stem cells and their secreted apoptotic extracellular vesicles: therapeutic applications and mechanisms | |
| WO2023146852A3 (en) | Methods and compositions for the production of cell-based meat products | |
| Rasaei et al. | Human pluripotent stem cell-derived macrophages and macrophage-derived exosomes: therapeutic potential in pulmonary fibrosis | |
| US20240052316A1 (en) | Stem cell priming composition and primed stem cell | |
| JP2014523252A5 (https=) | ||
| Ma et al. | The role of mesenchymal stem cells in hair regeneration and hair cycle | |
| Guo et al. | Exploring microenvironment strategies to delay mesenchymal stem cell senescence | |
| Rui et al. | Stem cell therapies and ageing: unlocking the potential of regenerative medicine | |
| Liu | Stemness of mesenchymal stem cells | |
| EP4257674A1 (en) | Method for isolating and culturing cord blood stem cells expressing gdf-3 at high level, and use of gdf-3 |